Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:4385643.
doi: 10.1155/2016/4385643. Epub 2016 Jul 4.

CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment

Mark Hull  1 , Stephen Shafran  2 , Alex Wong  3 , Alice Tseng  4 , Pierre Giguère  5 , Lisa Barrett  6 , Shariq Haider  7 , Brian Conway  8 , Marina Klein  9 , Curtis Cooper  10
Affiliations

CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment

Mark Hull et al. Can J Infect Dis Med Microbiol. 2016.

Abstract

Background. Hepatitis C virus (HCV) coinfection occurs in 20-30% of Canadians living with HIV and is responsible for a heavy burden of morbidity and mortality. Purpose. To update national standards for management of HCV-HIV coinfected adults in the Canadian context with evolving evidence for and accessibility of effective and tolerable DAA therapies. The document addresses patient workup and treatment preparation, antiviral recommendations overall and in specific populations, and drug-drug interactions. Methods. A standing working group with HIV-HCV expertise was convened by The Canadian Institute of Health Research HIV Trials Network to review recently published HCV antiviral data and update Canadian HIV-HCV Coinfection Guidelines. Results. The gap in sustained virologic response between HCV monoinfection and HIV-HCV coinfection has been eliminated with newer HCV antiviral regimens. All coinfected individuals should be assessed for interferon-free, Direct Acting Antiviral HCV therapy. Regimens vary in content, duration, and success based largely on genotype. Reimbursement restrictions forcing the use of pegylated interferon is not acceptable if optimal patient care is to be provided. Discussion. Recommendations may not supersede individual clinical judgement. Treatment advances published since December 2015 are not considered in this document.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nakagawa F., Lodwick R. K., Smith C. J., et al. Projected life expectancy of people with HIV according to timing of diagnosis. AIDS. 2012;26(3):335–343. doi: 10.1097/QAD.0b013e32834dcec9. - DOI - PubMed
    1. Samji H., Cescon A., Hogg R. S., et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS ONE. 2013;8(12) doi: 10.1371/journal.pone.0081355.e81355 - DOI - PMC - PubMed
    1. Ly K. N., Xing J., Klevens R. M., Jiles R. B., Ward J. W., Holmberg S. D. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Annals of Internal Medicine. 2012;156(4):271–278. doi: 10.7326/0003-4819-156-4-201202210-00004. - DOI - PubMed
    1. Klein M. B., Rollet K. C., Saeed S., et al. HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality. HIV Medicine. 2013;14(1):10–20. doi: 10.1111/j.1468-1293.2012.01028.x. - DOI - PubMed
    1. Weber R., Sabin C. A., Friis-Moller N., et al. Liver-related deaths in persons infected with the human immunodeficiency virus the D:A:D study. Archives of Internal Medicine. 2006;166(15):1632–1641. doi: 10.1001/archinte.166.15.1632. - DOI - PubMed

LinkOut - more resources